BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HONA

Go back to BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.67 -0.02 (0.74%)
Previous Close $2.69    52 Week High $1.63 
Open $2.72    52 Week Low $0.71 
Day High $2.72    P/E N/A 
Day Low $2.55    EPS $0.00 
Volume 27,938       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.67 -0.02 (0.74%)
Previous Close $2.69    52 Week High $1.63 
Open $2.72    52 Week Low $0.71 
Day High $2.72    P/E N/A 
Day Low $2.55    EPS $0.00 
Volume 27,938       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.67 -0.02 (0.74%)
Previous Close $2.69    52 Week High $1.63 
Open $2.72    52 Week Low $0.71 
Day High $2.72    P/E N/A 
Day Low $2.55    EPS $0.00 
Volume 27,938